Drug research

The shares of US biotech Viking Therapeutics have more than doubled since trial results for its weight-loss drug beat existing treatments from Novo Nordisk & Eli Lilly. In a mid-stage 13-week trial, Viking reported that its…

AstraZeneca announced on Monday that its top drug has shown promising results in treating early-stage lung cancer by slowing down the progression of the disease. The company announced that its Tagrisso drug, which is a best-seller,…

Mounjaro, a weight-loss drug that is available in an injectable pen in Great Britain in the near future for the treatment of diabetes and obesity will be made available by Eli Lilly after the UK medicines regulator approved its sale on…

According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…

Syntara's $10M capital raise is propelling its drug development strategy into a new era. In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic…

AstraZeneca has acquired its first vaccine company for $1.1bn. This will allow the company to expand its vaccine and immunotherapy business, which it established during the Covid pandemic. The largest drugmaker in Britain has agreed to…

Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them. Novo Nordisk, a maker of obesity drugs, said that it would offer countries the option to "buy now and pay later" for its…

AstraZeneca has contested accusations that the Covid-19 vaccine was "defective", after a vaccine patient sued for damages, claiming to have suffered a severe side-effect. The Anglo-Swedish pharmaceutical company, which developed the…

AstraZeneca will enter the race to develop a weight-loss pill. It is working on a new class of drugs, which it hopes to use in developing nations to combat obesity. The Anglo-Swedish pharmaceutical company announced on Thursday a…

Researchers from Eisai and Eli Lilly presented a study that showed the benefits for patients of using new Alzheimer's medications very early in its development. The Japanese pharmaceutical group Eisai has revealed that a new analysis…

AstraZeneca announced the full results of its trials at a medical conference on Monday, in an attempt to reassure investors about their plans to replace chemotherapy with a targeted drug. David Fredrickson said that it was "a massive…

Merck's chief research officer has called for the UK government make the country more welcoming of pharma companies. This is ahead of next week, when the US-based company will break ground in London on a £1bn Research Centre. Dean Li,…

GSK signed a contract with Zhifei - China's biggest vaccine company by revenue - to double the global sales of GSK's shingles vaccine before 2026. The UK-based company reported that Zhifei has agreed to purchase Shingrix from GSK, the…

Moderna's Covid-19 combined with influenza vaccine performed as well as separate shots during an early-stage trial. This gives the US biotech firm hope that the more convenient method of protection against diseases could be approved before…

The blockbuster drug Merck developed to treat Covid-19 was linked to mutations that are transmitted when coronaviruses spread between patients. This finding will increase scrutiny over its effectiveness and the billions of dollars spent by…

The UK has invested £210mn to track superbugs in Asia and Africa in order to combat antimicrobial resistance in Britain before these pathogens reach the country. The funding announcement was made on Wednesday, as Health Secretary Steve…

A booming weight-loss drug market has investors scrambling for a piece of the action After Copenhagen-headquartered Novo Nordisk published trial data this week suggesting its weight-loss jab Wegovy cut the risk of heart attacks…

Gunilla Osswald describes her final act at AstraZeneca in a quiet voice. After 28 years trying to develop treatments for brain disorders patients, she was given the "sad task" of closing a large Swedish Research and Development site in…